Rheure Alves Moreira Lopes

Rheure Alves Moreira Lopes is an Honorary Research Fellow at the University of Glasgow's School of Cardiovascular & Metabolic Health. Their primary research focuses on vascular biology, hypertension, and oxidative stress mechanisms, with a particular interest in redox signaling pathways and their implications in vascular dysfunction. Key areas of investigation include the role of PARP/TRPM2, NADPH oxidases, and chemerin receptors in cardiovascular diseases such as hypertension, diabetes, and post-COVID-19 conditions. Lopes has contributed to over 35 peer-reviewed articles and book chapters, exploring topics ranging from hormonal influences on vascular reactivity to therapeutic targets for hypertension.

Research interests prominently feature vascular dysfunction in hypertension, oxidative stress mechanisms in endothelial and smooth muscle cells, and the pathophysiological effects of hormones like testosterone. Their work bridges basic science with clinical applications, such as developing therapies targeting rho-kinase inhibition and evaluating ROS scavengers for genital skin healing in hypospadias. Lopes collaborates with international teams, including studies on aldosterone-induced vascular damage and the effects of high-fat diets on systemic oxidative stress.

Publications highlight contributions to understanding VEGF inhibitor side effects, TRPM7 channel regulation, and the role of Nrf2 in protecting against vascular injury. Recent studies investigate salt-induced vascular damage and post-COVID-19 vascular mechanisms, underscoring translational relevance. Despite prolific output, no academic awards are explicitly mentioned in the text.

Advising and grants involve collaborations on projects like testosterone's impact on vascular smooth muscle apoptosis and spironolactone's role in diabetic vascular protection. Their research often integrates molecular biology techniques with in vivo models, as demonstrated in methods chapters co-authored for hypertension protocols.